Rainbow Children's Medicare Future Growth
Future criteria checks 4/6
Rainbow Children's Medicare is forecast to grow earnings and revenue by 20.9% and 17.5% per annum respectively. EPS is expected to grow by 21.4% per annum. Return on equity is forecast to be 19.2% in 3 years.
Key information
20.9%
Earnings growth rate
21.4%
EPS growth rate
| Healthcare earnings growth | 26.1% |
| Revenue growth rate | 17.5% |
| Future return on equity | 19.2% |
| Analyst coverage | Good |
| Last updated | 29 Aug 2024 |
Recent future growth updates
Earnings Miss: Rainbow Children's Medicare Limited Missed EPS By 5.1% And Analysts Are Revising Their Forecasts
Aug 16
Analysts Have Made A Financial Statement On Rainbow Children's Medicare Limited's (NSE:RAINBOW) Full-Year Report
May 23Recent updates
Earnings Miss: Rainbow Children's Medicare Limited Missed EPS By 5.1% And Analysts Are Revising Their Forecasts
Aug 16Rainbow Children's Medicare (NSE:RAINBOW) Is Experiencing Growth In Returns On Capital
Jun 26Rainbow Children's Medicare (NSE:RAINBOW) Strong Profits May Be Masking Some Underlying Issues
May 27Analysts Have Made A Financial Statement On Rainbow Children's Medicare Limited's (NSE:RAINBOW) Full-Year Report
May 23Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?
May 07Some Shareholders Feeling Restless Over Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E Ratio
Mar 20Returns At Rainbow Children's Medicare (NSE:RAINBOW) Are On The Way Up
Feb 13Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?
Jan 18Impressive Earnings May Not Tell The Whole Story For Rainbow Children's Medicare (NSE:RAINBOW)
Nov 07Here's Why Rainbow Children's Medicare (NSE:RAINBOW) Has Caught The Eye Of Investors
Oct 18A Look At The Fair Value Of Rainbow Children's Medicare Limited (NSE:RAINBOW)
Aug 29With EPS Growth And More, Rainbow Children's Medicare (NSE:RAINBOW) Makes An Interesting Case
Jul 08Earnings Beat: Rainbow Children's Medicare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
May 18Getting In Cheap On Rainbow Children's Medicare Limited (NSE:RAINBOW) Is Unlikely
Feb 11Are Investors Undervaluing Rainbow Children's Medicare Limited (NSE:RAINBOW) By 24%?
Sep 20Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 21,781 | 3,764 | 2,085 | N/A | 5 |
| 3/31/2026 | 18,502 | 3,121 | 2,587 | N/A | 9 |
| 3/31/2025 | 15,449 | 2,374 | 1,786 | N/A | 9 |
| 6/30/2024 | 13,400 | 2,155 | N/A | N/A | N/A |
| 3/31/2024 | 12,969 | 2,170 | -322 | 3,214 | N/A |
| 12/31/2023 | 12,728 | 2,196 | N/A | N/A | N/A |
| 9/30/2023 | 12,432 | 2,154 | 56 | 3,299 | N/A |
| 6/30/2023 | 12,236 | 2,136 | N/A | N/A | N/A |
| 3/31/2023 | 11,736 | 2,108 | 1,875 | 3,288 | N/A |
| 12/31/2022 | 10,691 | 1,690 | N/A | N/A | N/A |
| 9/30/2022 | 10,114 | 1,560 | 1,294 | 2,248 | N/A |
| 6/30/2022 | 9,646 | 1,405 | N/A | N/A | N/A |
| 3/31/2022 | 9,738 | 1,378 | 1,615 | 2,237 | N/A |
| 12/31/2021 | 9,252 | 1,269 | 1,856 | 2,454 | N/A |
| 9/30/2021 | 8,528 | 972 | 1,598 | 2,311 | N/A |
| 6/30/2021 | 7,415 | 642 | N/A | N/A | N/A |
| 3/31/2021 | 6,500 | 400 | 666 | 1,427 | N/A |
| 3/31/2020 | 7,194 | 549 | 959 | 1,704 | N/A |
| 3/31/2019 | 5,428 | 443 | 398 | 1,272 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RAINBOW's forecast earnings growth (20.9% per year) is above the savings rate (6.7%).
Earnings vs Market: RAINBOW's earnings (20.9% per year) are forecast to grow faster than the Indian market (16.9% per year).
High Growth Earnings: RAINBOW's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: RAINBOW's revenue (17.5% per year) is forecast to grow faster than the Indian market (10% per year).
High Growth Revenue: RAINBOW's revenue (17.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RAINBOW's Return on Equity is forecast to be low in 3 years time (19.2%).